SCOPOLAMINE TRANSDE

The Defense Logistics Agency awarded a delivery order under basic contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of 7.000 patches of Scopolamine Transdermal (NSN 6505014562380) at a total price of $458.36. The award was issued on July 14, 2026, with delivery required by July 29, 2026, to Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor bears all freight costs and risks until receipt at the destination. The contract is structured as a single-line-item call against an indefinite-delivery, indefinite-quantity basic contract and carries no options or quantity variances. Payment is governed by Net 30 days terms and requires electronic invoicing in compliance with DFARS 252.232-7003, likely through the Department of Defense's designated systems. The contracting officer is Lisa Quinn, and the administering office is DLA Troop Support’s Medical Supply Chain Pharmacy FSA in Philadelphia, Pennsylvania, with payments remitted to the Defense Finance and Accounting Service in Columbus, Ohio. Packaging must be shipped via the fastest traceable means, excluding parcel post, and must include proper MARKFOR designations, though no detailed MIL-STD labeling or preservation specifications are provided. Inspection and acceptance occur at the destination by the government, with the contractor responsible for conformance to contract requirements. No socioeconomic certifications, special contract requirements, or detailed evaluation factors are documented, and Section I clauses and Section K representations are not present in the provided materials, suggesting reliance on the underlying basic contract for those provisions. The NAICS code is 424210, and the transaction is classified as a federal award with no set-aside designation.